INCY

Incyte Corporation (INCY)

Last Price$70.5(3.7%)
Market Cap$13.5B
LTM ROIC - WACC
(24.0%)
5Y avg
13.9%
Biotechnology industry median
(127.8%)
Stock quality & Intrinsic value
5/10
0.1% undervalued

Incyte Corporation ROIC - WACC

Annual
Quarterly
LTM
Industry median
Company stand-alone
INCY
Healthcare
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
ROIC - WACC
(485.3%)
(425.7%)
(563.4%)
(1,968.0%)
3,800.9%
(264.7%)
(14.6%)
(1,178.2%)
(3.5%)
(34.9%)
(11.2%)
29.1%
28.1%
(37.7%)
8.1%
32.9%
(30.2%)
61.8%
18.2%
16.1%
INCY
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for INCY and see if it's the right time to invest.
Dive in

Incyte Corporation (INCY) ROIC - WACC comparison analysis

Crunching data... Almost there!

INCY key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is Incyte Corporation's ROIC - WACC?

As of today, Microsoft Corp's last 12-month ROIC - WACC is (24.0%), based on the financial report for Sep 30, 2024 (Q3 2024). The average annual ROIC - WACC for Incyte Corporation have been 24.4% over the past three years, and 14.6% over the past five years.

2) Is Incyte Corporation's ROIC - WACC Good?

As of today, Incyte Corporation's ROIC - WACC is (24.0%), which is higher than industry median of (127.8%). It indicates that Incyte Corporation's ROIC - WACC is Good.

3) How does Incyte Corporation's ROIC - WACC compare to its peers?

As of today, Incyte Corporation's ROIC - WACC is (24.0%), which is lower than peer median of (11.7%). The list of peers includes UTHR, NVO, REGN, GMAB, VRTX, ALNY, BGNE, BNTX, MRNA, ARGX.